Fumio Hirano

5PUBLICATIONS
14CO-AUTHORS
Arts therapyDisease surveillanceMedical infection agents (incl. prions)Gene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 01, 2024
Effectiveness and safety of treat-to-target strategy for methotrexate-naïve rheumatoid arthritis patients >75 years of age.

Takumi Matsumoto, Takahiko Sugihara, Tadashi Hosoya

|Jan 07, 2021
Effectiveness and safety of treat-to-target strategy in elderly-onset rheumatoid arthritis: a 3-year prospective observational study.

Takahiko Sugihara, Tatsuro Ishizaki, Wataru Onoguchi

|Nov 02, 2020
An open-label, randomized controlled trial of sulfamethoxazole-trimethoprim for Pneumocystis prophylaxis: results of 52-week follow-up.

Masako Utsunomiya, Hiroaki Dobashi, Toshio Odani

|Sep 28, 2020
Determinants of the Physician Global Assessment of Disease Activity and Influence of Contextual Factors in Early Axial Spondyloarthritis.

Fumio Hirano, Robert B M Landewé, Floris A van Gaalen

|Nov 10, 2019
Association of NCF1 polymorphism with systemic lupus erythematosus and systemic sclerosis but not with ANCA-associated vasculitis in a Japanese population.

Nozomi Yokoyama, Aya Kawasaki, Takashi Matsushita

Pageof 1

Frequent Collaborators

2 joint publications

Tadashi Hosoya

2 joint publications

Takahiko Sugihara

2 joint publications

Mari Kamiya

1 joint publications

Takashi Matsushita